Brandon Couillard
Stock Analyst at Wells Fargo
(4.89)
# 291
Out of 4,703 analysts
702
Total ratings
63.5%
Success rate
18.7%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MLAB Mesa Laboratories | Rated: Hold | $94 → $110 | $127.78 | -13.91% | 15 | Aug 14, 2026 | |
| NTRA Natera | Maintained: Hold | $220 → $284 | $328.18 | -13.46% | 6 | Aug 7, 2026 | |
| BLLN BillionToOne | Maintained: Hold | $90 | $99.39 | -9.45% | 6 | Aug 6, 2026 | |
| BIO Bio-Rad Laboratories | Rated: Hold | $310 → $330 | $386.11 | -14.53% | 57 | Aug 5, 2026 | |
| WGS GeneDx Holdings | Maintained: Buy | $75 | $85.99 | -12.78% | 15 | Aug 4, 2026 | |
| MYGN Myriad Genetics | Maintained: Hold | $5.5 → $3 | $3.19 | -5.96% | 31 | Aug 2, 2026 | |
| AVTR Avantor | Maintained: Buy | $14 → $16 | $14.97 | +6.88% | 19 | Jul 30, 2026 | |
| GH Guardant Health | Maintained: Buy | $125 | $161.41 | -22.56% | 9 | Jul 29, 2026 | |
| TMO Thermo Fisher Scientific | Rated: Buy | $615 | $613.78 | +0.20% | 42 | Jul 23, 2026 | |
| DHR Danaher | Maintained: Hold | $212 → $195 | $207.66 | -6.10% | 53 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $72.43 | -14.40% | 6 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $165 → $160 | $150.86 | +6.06% | 55 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $355 → $370 | $409.38 | -9.62% | 29 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $190 → $180 | $167.60 | +7.40% | 29 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $21 | $50.88 | -58.73% | 11 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $107 → $110 | $130.22 | -15.53% | 38 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $55 | $58.50 | -5.98% | 40 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1,400 → $1,450 | $1,345.26 | +7.79% | 25 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $4.5 | $7.32 | -38.52% | 12 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $17 | $15.81 | n/a | 4 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $88 → $81 | $89.81 | n/a | 21 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $38 | $11.38 | n/a | 25 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $23 | $27.28 | n/a | 6 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $305 → $325 | $158.64 | n/a | 43 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 | $327.21 | n/a | 26 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $0.9049 | n/a | 2 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 | $1.46 | n/a | 7 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $16 → $15 | $3.48 | n/a | 20 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $280 → $300 | $184.74 | n/a | 17 | May 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 → $4.5 | $1.64 | n/a | 16 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 → $1.75 | $0.2782 | n/a | 11 | Jul 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $116 | $66.53 | n/a | 1 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26 | $43.47 | n/a | 5 | Nov 22, 2016 |
Mesa Laboratories
Aug 14, 2026
Rated: Hold
Price Target: $94 → $110
Current: $127.78
Upside: -13.91%
Natera
Aug 7, 2026
Maintained: Hold
Price Target: $220 → $284
Current: $328.18
Upside: -13.46%
BillionToOne
Aug 6, 2026
Maintained: Hold
Price Target: $90
Current: $99.39
Upside: -9.45%
Bio-Rad Laboratories
Aug 5, 2026
Rated: Hold
Price Target: $310 → $330
Current: $386.11
Upside: -14.53%
GeneDx Holdings
Aug 4, 2026
Maintained: Buy
Price Target: $75
Current: $85.99
Upside: -12.78%
Myriad Genetics
Aug 2, 2026
Maintained: Hold
Price Target: $5.5 → $3
Current: $3.19
Upside: -5.96%
Avantor
Jul 30, 2026
Maintained: Buy
Price Target: $14 → $16
Current: $14.97
Upside: +6.88%
Guardant Health
Jul 29, 2026
Maintained: Buy
Price Target: $125
Current: $161.41
Upside: -22.56%
Thermo Fisher Scientific
Jul 23, 2026
Rated: Buy
Price Target: $615
Current: $613.78
Upside: +0.20%
Danaher
Jul 22, 2026
Maintained: Hold
Price Target: $212 → $195
Current: $207.66
Upside: -6.10%
Jun 26, 2026
Maintained: Buy
Price Target: $62
Current: $72.43
Upside: -14.40%
May 28, 2026
Maintained: Buy
Price Target: $165 → $160
Current: $150.86
Upside: +6.06%
May 14, 2026
Maintained: Hold
Price Target: $355 → $370
Current: $409.38
Upside: -9.62%
Feb 25, 2026
Maintained: Buy
Price Target: $190 → $180
Current: $167.60
Upside: +7.40%
Feb 25, 2026
Maintained: Hold
Price Target: $18 → $21
Current: $50.88
Upside: -58.73%
Feb 3, 2026
Maintained: Hold
Price Target: $107 → $110
Current: $130.22
Upside: -15.53%
Dec 15, 2025
Maintained: Buy
Price Target: $50 → $55
Current: $58.50
Upside: -5.98%
Dec 15, 2025
Maintained: Hold
Price Target: $1,400 → $1,450
Current: $1,345.26
Upside: +7.79%
Dec 15, 2025
Maintained: Buy
Price Target: $4 → $4.5
Current: $7.32
Upside: -38.52%
Mar 13, 2024
Maintained: Buy
Price Target: $21 → $17
Current: $15.81
Upside: n/a
Mar 6, 2024
Maintained: Hold
Price Target: $88 → $81
Current: $89.81
Upside: n/a
Feb 29, 2024
Maintained: Buy
Price Target: $36 → $38
Current: $11.38
Upside: n/a
Feb 9, 2024
Downgraded: Hold
Price Target: $32 → $23
Current: $27.28
Upside: n/a
Feb 1, 2024
Maintained: Buy
Price Target: $305 → $325
Current: $158.64
Upside: n/a
Aug 29, 2022
Maintained: Buy
Price Target: $200
Current: $327.21
Upside: n/a
May 4, 2022
Maintained: Buy
Price Target: $13 → $11
Current: $0.9049
Upside: n/a
Jun 18, 2021
Rated: Buy
Price Target: $26
Current: $1.46
Upside: n/a
Aug 6, 2020
Rated: Hold
Price Target: $16 → $15
Current: $3.48
Upside: n/a
May 18, 2020
Maintained: Buy
Price Target: $280 → $300
Current: $184.74
Upside: n/a
Aug 8, 2018
Reiterated: Hold
Price Target: $3.5 → $4.5
Current: $1.64
Upside: n/a
Jul 27, 2018
Reiterated: Buy
Price Target: $2 → $1.75
Current: $0.2782
Upside: n/a
May 31, 2017
Reiterated: Buy
Price Target: $116
Current: $66.53
Upside: n/a
Nov 22, 2016
Reiterated: Hold
Price Target: $26
Current: $43.47
Upside: n/a